Skip to content

Raksha Kulkarni, MD

NPI 1780305540ActiveIndividual· Nuclear Medicine· New York, NY

Nuclear Medicine (MD) in New York, New York, licensed in NY, with an NPI issued in September 2022. Telix Pharmaceuticals reported $86.55 in payments in 2025, mostly food and beverage.

Overview

NPI1780305540
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedSep 8, 2022
Last updated in NPPESSep 15, 2026
Certified by providerSep 15, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Nuclear Medicine Primary207U00000X347400NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$86.55 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Telix Pharmaceuticals$86.551

What the 2025 payments were for

  • Food and Beverage$86.55 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Nuclear Medicine providers in New York

All 46 Nuclear Medicine providers in New York · All Nuclear Medicine providers in New York